Concepedia

Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy

Oliver Van Oekelen, Adolfo Aleman, Bhaskar Upadhyaya, Sandra Schnakenberg, Deepu Madduri, Somali Gavane, Julie Teruya‐Feldstein, John F. Crary, Mary Fowkes, Charles B. Stacy,

Nature Medicine · 2021 · 256 citations · 20 references

DOIFull text

Open access

Concepts

References

20

An anatomically comprehensive atlas of the adult human brain transcriptome

Michael Hawrylycz, Ed S. Lein, Angela Guillozet-Bongaarts et al. · Nature · 2012 · 3.3K citations · Full text

, , +14

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Nikhil C. Munshi, Larry D. Anderson, Nina Shah et al. · New England Journal of Medicine · 2021 · 2.4K citations · Full text

, , +17

FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data

Sofie Van Gassen, Britt Callebaut, Mary J. van Helden et al. · Cytometry Part A · 2015 · 2.1K citations

, , +12

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Noopur Raje, Jesús G. Berdeja, Yi Lin et al. · New England Journal of Medicine · 2019 · 1.7K citations · Full text

, , +17

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani et al. · The Lancet · 2021 · 1.7K citations

, , +17